Spring direct naar de hoofdnavigatie of de inhoud

Mark Einerhand

Patent attorney

“In the end it's all about the value that the patent adds to the product.”
Home / Experts / Mark Einerhand

Mark Einerhand

Mark Einerhand

  • Life Sciences
  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner

Mark Einerhand has been active in the patent world since 1998, when he made the switch from a biotech startup to V.O.

Mark’s career started in science. After his studies of molecular biology at the University of Amsterdam, he took his PhD in medical science inLeiden, in 1992. He was a visiting scientist at Cornell University in New York and the MRC at Mill Hill in London.

More information about Mark

His particular expertise lies in the field of medical (bio)technology, diagnostics and medicines. Because of his background at Introgene/Crucell, Mark has a special affinity with Life Science startups. He has a wide experience in patent cases before the court in The Hague.

Working experience

  • Patent Attorney, V.O. (1998-present)
  • IntroGene (now Crucell), Rijswijk (1995)
  • Post-Doc at Leiden University (1993)
  • Medical Research Council, Mill Hill, London (1992)
  • Visiting Scientist, Cornell University New York (1992)

Education

  • PhD in Medicine, Leiden University (1992)
  • MSc in Biochemistry, University of Amsterdam (1987), Major in Molecular Oncology, Dutch Cancer Institute

Publications

  • Co-author of article ‘The patentability of stem cells in Europe’, IAM Life Sciences 2015.
    Einerhand, M.P.W. (2011): Advance offering of generics found to infringe. Managing Intellectual Property: Vol 205: page: 87.
  • Einerhand M.P.W. (2010): A contribution to: Legal and intellectual property issues associated with stem cells. In: Stem Cells; scientific facts and fiction, (C. Mummery; I. Wilnut, A van de Stolpe and
    B.A.J. Roelen), Academic Press: Elsevier.
  • Einerhand M.P.W. and van Melle, J (2004): Patenting of inventions in the field of bio-informatics.
    In: The new avenues in Bioinformatics, (Seckbach, J and Rubin, E eds), Kluwer Academic Publishers, the Netherlands.
  • Principle inventor on Patents and Patent Applications: Einerhand, M.P.W. and Valerio (1997). WO 98/32870: US 6,232,105: A conditional replication and expression system. Einerhand, M.P.W. and Valerio (1997). WO 99/32647: Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into chromosomal DNA of target cells in gene therapy. Einerhand, M.P.W. and Valerio (1996). WO98/24924: NZ 336185:
  • Transduction of primate hemopoietic repopulating stem cells. Einerhand, M.P.W. and Valerio (1995). WO 97/20943: US 6,140,103: Regulated protein expression in stably transfected mammalian cells. Einerhand, M.P.W. (1992) Gene transfer into hemopoietic stem cells: prospects for human gene therapy. University of Leiden.

Professional & Community Activities

  • Member of the Steering Committee World IP Forum 2015
    Former member of the European Qualifying Examination committee III

Languages

  • English
  • Dutch
  • German

Also see these experts

Frits Schut

  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner

Jennifer Ebner von Eschenbach

  • European Patent Attorney
  • Senior Associate
More experts

News

The Nagoya Protocol and its impact on your research

The Nagoya Protocol is often believed to apply exclusively to the plant breeding sector. However, the influence of the protocol reaches much further. Almost everyone utilizing genetic resources for research may have to deal with it. From individuals and universities to multinationals in all sectors, everyone needs to check whether their research is covered by […]Continue reading

Childhood dream comes true in the circular economy

They met at Nedstaal and now the three of them are busy getting a revolutionary business off the ground. Purified Metal Company (PMC) in Delfzijl will soon clean contaminated scrap for reuse. Director Jan Henk Wijma: “This is a childhood dream. It began on a sheet of A4 and now we’ve almost come so far […]Continue reading

Are the symbols ® and ™ symbol politics or are they relevant?

Businesses wanting to sell their own brands on the market often use the symbols ® and ™. We are often not aware of the implications of these symbols, but they are used to give a brand an allure.  Rather, case law shows that the use of these symbols can have significant, important consequences.Continue reading

Events

IPPLA 3rd Annual Meeting 2018

Omni Hotel, California Street, San Francisco, Californië, USA

Annual Meeting of International Intellectual Property Law Association, Inc. (IIPLA) is the leading event in the West USA. Attended by hundreds of participants from more than 35+ countries. More about this event

Improve your practical knowledge at the IP Academy – Basic

Winthontlaan 6, 3526 KV Utrecht, Utrecht, Netherlands

Follow the annual course on patents, trademarks and designs. For innovative entrepreneurs who wish to improve their intellectual property (IP) know-how, V.O. Patents & Trademarks organizes a basic course on IP on Thursday 1 November 2018. More about this event

BIO-EUROPE

Bella Center, Center Boulevard, København, Denemarken

BIO-EUROPE brings together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, strategic panel discussions and more. More about this event